Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allergy, Astrazeneca, Atsena, Crinetics, Dimerix, Ionis, Longboard, Neurobo, Ocugen, Silence, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Acadia, Azafaros, Imugene, Larimar, Neurosense, Newamsterdam, Pfizer, Recce, Regulus, Sirpant.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Allyx, Alumis, Arcutis, Bioarctic, Dermavant, Eisai, Eli Lilly, Galderma, Immunabs, Immuneering, Incyte, Leo, Moonlake, Remegen, Replay, Sanofi, Sensorion, Synnovation, Timber, Tonix, UCB, Ventyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Akero, Amylyx, Arrowhead, Athira, Curasen, Inventiva, Kiora, Promontory, Regeneron, Spisparc, Vaxxinity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Alphyn, Arch, Gabather, Gilead, GSK, Immuron, Nodthera, Persica, Salix, Ultimovacs, Upstream, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Biogen, Biomea, Gilead, Grace, Innate, Kura, Laminar, Maia, Nektar, Oncusp, Telios.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Alzecure, Ankyra, Apogee, Bioinvent, Cervomed, Constant, Cynata, Elysium, Exonate, FSD, Immunitybio, Immutep, Inmune, Maat, Modex, Nielsen, Novo Nordisk, Regenxbio, Viiv, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Atai, Audion, Avidity, Berlin, Biocardia, Neurogene, Novartis, Nrx, Solascure, Ultimovacs, Vaxcyte, Vivoryon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beigene, Biovie, Bone Biologics, Cardiff Oncology, Innovent, Maat, Oncopeptides, Sellas, Sonnet.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biomind, BMS, Clene, Ironwood, Mithra, Neurobo, Pfizer, Taysha, Viracta, Vivacelle.